Eli Lilly says expanded Medicare GLP-1 coverage adds patients

CEO Dave Ricks tells CNBC that about 700,000 new seniors started GLP-1 drugs since Medicare coverage began in July, with roughly seven out of the new patients treated with Lilly's Mounjaro/Zepbound, per the article.